H1 Secures $40M from CVS for AI-driven Healthcare Data
TL;DR. H1, a healthcare data intelligence company, closed a $40 million funding round led by CVS Health Ventures to expand its platform. - CEO Ariel Katz states AI cannot replicate H1's specialized doctor data collection and synthesis. - The investment will help H1 grow its real-world data and clinical trial solutions. - H1 connects healthcare professionals and researchers with relevant scientific and clinical data.
- H1 raised $40 million in funding led by CVS Health Ventures.
- The company provides a healthcare data intelligence platform used by pharmaceutical companies and healthcare organizations.
- H1's CEO emphasizes that while AI can replicate workflow SaaS, it cannot replicate H1's unique doctor data and insights.
- The funding will support H1's expansion and product development in real-world evidence and clinical trials.